All in all, CTLA4 changed the landscape of TILs in ccRCC TME, and indicated a higher density of TILs, especially the CD8+ T cells and Tregs, but faced an immunosuppressed phenotype. Here, CTLA4 is linked to nonpapillary renal cell carcinoma.